528 related articles for article (PubMed ID: 17138955)
1. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit.
Hermans G; Wilmer A; Meersseman W; Milants I; Wouters PJ; Bobbaers H; Bruyninckx F; Van den Berghe G
Am J Respir Crit Care Med; 2007 Mar; 175(5):480-9. PubMed ID: 17138955
[TBL] [Abstract][Full Text] [Related]
2. Insulin therapy protects the central and peripheral nervous system of intensive care patients.
Van den Berghe G; Schoonheydt K; Becx P; Bruyninckx F; Wouters PJ
Neurology; 2005 Apr; 64(8):1348-53. PubMed ID: 15851721
[TBL] [Abstract][Full Text] [Related]
3. Intensive insulin therapy in the medical ICU.
Van den Berghe G; Wilmer A; Hermans G; Meersseman W; Wouters PJ; Milants I; Van Wijngaerden E; Bobbaers H; Bouillon R
N Engl J Med; 2006 Feb; 354(5):449-61. PubMed ID: 16452557
[TBL] [Abstract][Full Text] [Related]
4. Metabolic aspects of critical illness polyneuromyopathy.
Hermans G; Vanhorebeek I; Derde S; Van den Berghe G
Crit Care Med; 2009 Oct; 37(10 Suppl):S391-7. PubMed ID: 20046125
[TBL] [Abstract][Full Text] [Related]
5. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.
Arabi YM; Dabbagh OC; Tamim HM; Al-Shimemeri AA; Memish ZA; Haddad SH; Syed SJ; Giridhar HR; Rishu AH; Al-Daker MO; Kahoul SH; Britts RJ; Sakkijha MH
Crit Care Med; 2008 Dec; 36(12):3190-7. PubMed ID: 18936702
[TBL] [Abstract][Full Text] [Related]
6. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality.
Arabi YM; Tamim HM; Rishu AH
Crit Care Med; 2009 Sep; 37(9):2536-44. PubMed ID: 19623047
[TBL] [Abstract][Full Text] [Related]
8. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness.
Fletcher SN; Kennedy DD; Ghosh IR; Misra VP; Kiff K; Coakley JH; Hinds CJ
Crit Care Med; 2003 Apr; 31(4):1012-6. PubMed ID: 12682465
[TBL] [Abstract][Full Text] [Related]
9. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial.
Bilotta F; Spinelli A; Giovannini F; Doronzio A; Delfini R; Rosa G
J Neurosurg Anesthesiol; 2007 Jul; 19(3):156-60. PubMed ID: 17592345
[TBL] [Abstract][Full Text] [Related]
10. [Critical illness neuropathies].
Magistris MR
Rev Neurol (Paris); 2002 Mar; 158(3):293-9. PubMed ID: 11976588
[TBL] [Abstract][Full Text] [Related]
11. [Impact of intensive insulin therapy on surgical critically ill patients].
He W; Zhang TY; Zhou H; Li T; Zhao JY; Zhao D; Liu XH; Hou J; Wang C; Xu Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(15):1052-4. PubMed ID: 18005588
[TBL] [Abstract][Full Text] [Related]
12. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.
Van den Berghe G; Wilmer A; Milants I; Wouters PJ; Bouckaert B; Bruyninckx F; Bouillon R; Schetz M
Diabetes; 2006 Nov; 55(11):3151-9. PubMed ID: 17065355
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular disease and respiratory failure.
Hutchinson D; Whyte K
Pract Neurol; 2008 Aug; 8(4):229-37. PubMed ID: 18644909
[TBL] [Abstract][Full Text] [Related]
14. Intensive care unit-acquired weakness: risk factors and prevention.
de Jonghe B; Lacherade JC; Sharshar T; Outin H
Crit Care Med; 2009 Oct; 37(10 Suppl):S309-15. PubMed ID: 20046115
[TBL] [Abstract][Full Text] [Related]
15. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
Cochrane Database Syst Rev; 2009 Jan; (1):CD006832. PubMed ID: 19160304
[TBL] [Abstract][Full Text] [Related]
16. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review.
Williams S; Horrocks IA; Ouvrier RA; Gillis J; Ryan MM
Pediatr Crit Care Med; 2007 Jan; 8(1):18-22. PubMed ID: 17251877
[TBL] [Abstract][Full Text] [Related]
17. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients.
Derde S; Hermans G; Derese I; Güiza F; Hedström Y; Wouters PJ; Bruyninckx F; D'Hoore A; Larsson L; Van den Berghe G; Vanhorebeek I
Crit Care Med; 2012 Jan; 40(1):79-89. PubMed ID: 21926599
[TBL] [Abstract][Full Text] [Related]
18. Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study.
Bland DK; Fankhanel Y; Langford E; Lee M; Lee SW; Maloney C; Rogers M; Zimmerman G
Am J Crit Care; 2005 Sep; 14(5):370-6. PubMed ID: 16120888
[TBL] [Abstract][Full Text] [Related]
19. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.
Ingels C; Debaveye Y; Milants I; Buelens E; Peeraer A; Devriendt Y; Vanhoutte T; Van Damme A; Schetz M; Wouters PJ; Van den Berghe G
Eur Heart J; 2006 Nov; 27(22):2716-24. PubMed ID: 16608860
[TBL] [Abstract][Full Text] [Related]
20. Clinical approach to the weak patient in the intensive care unit.
Dhand UK
Respir Care; 2006 Sep; 51(9):1024-40; discussion 1040-1. PubMed ID: 16934166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
